Partnering with the Cleveland Clinic
The Hebrew University and the Cleveland Clinic have joined together to develop and fund the Global Center for Transformative Nanomedicine, intended to advance nanotechnology research that has the potential to make a tremendous impact in health and medicine.
“Our two institutions will leverage resources and begin to combine our scientific knowledge,” said Prof. Menahem Ben-Sasson, Chancellor, The Hebrew University of Jerusalem. “These powerful interactions will expedite better medical treatments, more rapid, cost-effective diagnostics, and improved healthcare delivery for people the world over.”
One of the research teams is focused on the microbiome, specifically a suspected connection between gut bacteria imbalances and breast cancer. Another team seeks to harness nanotechnology and stem cell therapies to treat glioblastoma, the most common and aggressive form of brain cancer. Yet another team seeks to develop new therapies and probes for malignant melanoma, a deadly disease. This collaboration will focus on cardiovascular and neurodegenerative diseases as well.
“We are honored to join with Hebrew University to advance the emerging field of nanotechnology,” said Toby Cosgrove, M.D., President and CEO of Cleveland Clinic. “The Center for Transformative Nanomedicine will ensure development of novel therapeutics to improve longevity, enhance patient well-being, make medical care more cost-effective, and provide dynamic solutions to global health concerns.”
Nanotechnology enables doctors and other healthcare professionals to deliver medications to select sites, preventing drugs from degrading in the body before reaching targeted sites because the miniscule particles are protected. It is truly revolutionary work with the potential to change the way medicine is practiced while simultaneously saving lives all over the world.